CLINICAL_TRIALS
trial_result
· 2012-05-25
Clinical Trial Update: A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes [Phase 1]
Summary
A first-in-human Phase 1 study of LY2409021 in healthy participants and participants with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED